Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Labanca

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|March 15, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet NeedsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Journal of Geriatric Oncology|March 9, 2025
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort studyEnrica Antonia Martino, Ernesto Vigna, Paola De Luca, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
British Journal of Haematology|March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integrationSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|March 15, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet NeedsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Journal of Geriatric Oncology|March 9, 2025
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort studyEnrica Antonia Martino, Ernesto Vigna, Paola De Luca, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
British Journal of Haematology|March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integrationSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Pageof 6